CH0019396990
CH0019396990
YPSOMED HLDG
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2026 | 2025 | Change % |
|---|---|---|---|
| Total Revenue | 730.982.000 | 748.866.000 | 2.4% |
| Cost of Revenue | 416.376.000 | 456.801.000 | 8.8% |
| Gross Profit | 314.606.000 | 292.066.000 | 7.7% |
| 68.531.000 | 179.215.000 | 61.8% | |
| Operating Income | 246.075.000 | 112.851.000 | 118.1% |
| Pretax Income | 240.969.000 | 104.315.000 | 131.0% |
| Net Income Common Stockholders | 221.927.000 | 87.504.000 | 153.6% |
| -- | -- | -- | |
| -- | -- | -- |